AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Triglimicid V 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Brigade Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Triglimicid V 1mg/500mg/0.2mg Tablet

DiaBeta-V 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus, aiding in blood glucose regulation. DiaBeta-V should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on individual response and blood glucose monitoring. Continuous use is crucial; discontinuation without medical supervision may lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms – sweating, dizziness, headache, and trembling – and how to manage them. Regular meals and carrying a rapid-acting glucose source (e.g., sugary snacks or juice) are essential precautions. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. DiaBeta-V is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Its suitability for pregnant or breastfeeding women requires medical consultation. Regular blood glucose monitoring is necessary; your doctor may also order blood tests to assess blood cell counts and liver function.

Uses of Triglimicid V 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Triglimicid V 1mg/500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Triglimicid V 1mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Consume the tablet on an empty stomach.

Common Side effects of Triglimicid V 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Triglimicid V 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Triglimicid V 1mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.

How Triglimicid V 1mg/500mg/0.2mg Tablet works:

Each Triglimicid V tablet (1mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Triglimicid V 1mg/500mg/0.2mg tablets with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Triglimicid V 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Triglimicid V 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Triglimicid V 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Triglimicid V 1mg/500mg/0.2mg Tablets is discouraged for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Triglimicid V 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; the medication is contraindicated in patients with severe liver disease.

What if you forget to take Triglimicid V 1mg/500mg/0.2mg Tablet :

Should you forget a Triglimicid V 1mg/500mg/0.2mg Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Triglimicid V 1mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Triglimicid V 1mg/500mg/0.2mg Tablet

Triglimicid V 1mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This medication treats type 2 diabetes mellitus in adults, enhancing blood glucose control when combined with a healthy diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood glucose. This formulation is unsuitable for type 1 diabetes.
Taking Triglimicid V 1mg/500mg/0.2mg Tablets may result in common side effects including low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin reactions, and respiratory infections.
Patients with hypersensitivity to any ingredient or inactive component of Triglimicid V 1mg/500mg/0.2mg Tablet should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Combining Triglimicid V 1mg/500mg/0.2mg tablets and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and heightened lactic acidosis probability.
Indeed, Triglimicid V 1mg/500mg/0.2mg Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremors. This risk increases with missed or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Triglimicid V 1mg/500mg/0...
70
MRP 85
17% off